Degradable haemostat composition
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 16, 2018
Issued Date -
N/A
app pub date -
May 28, 2014
filing date -
May 30, 2013
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The present invention relates to a fibrous haemostat composition that is able to safely gradually and fully degrade in a human or animal body within about 30 days and so can be utilized by physicians to stem a flow of blood and promote healing both after as well as during surgical procedures.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2014 Application Filing Year
- C08B Class
- 356 Applications Filed
- 308 Patents Issued To-Date
- 86.52 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C08B Class
- 0 % this patent is cited more than
- 7 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Jul 16, 2025 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jul 16, 2029 |
